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Abstract
Bartonella henselae is able to internalize endothelial progenitor cells (EPCs), which are resistant to the infection of other
common pathogens. Bacteroides fragilis is a gram-negative anaerobe belonging to the gut microflora. It protects from
experimental colitis induced by Helicobacter hepaticus through the polysaccharide A (PSA). The aim of our study was to
establish: 1) whether B. fragilis colonization could protect from B. henselae infection; if this event may have beneficial effects
on EPCs, vascular system and tissues. Our in vitro results establish for the first time that B. fragilis can internalize EPCs and
competes with B. henselae during coinfection. We observed a marked activation of the inflammatory response by Real-time
PCR and ELISA in coinfected cells compared to B. henselae-infected cells (63 vs 23 up-regulated genes), and after EPCs
infection with mutant B. fragilis DPSA (>90% up-regulated genes) compared to B. fragilis. Interestingly, in a mouse model of
coinfection, morphological and ultrastructural analyses by hematoxylin-eosin staining and electron microscopy on murine
tissues revealed that damages induced by B. henselae can be prevented in the coinfection with B. fragilis but not with its
mutant B. fragilis DPSA. Moreover, immunohistochemistry analysis with anti-Bartonella showed that the number of positive
cells per field decreased of at least 50% in the liver (2064 vs 5068), aorta (561 vs 1062) and spleen (2563 vs 4066)
sections of mice coinfected compared to mice infected only with B. henselae. This decrease was less evident in the
coinfection with DPSA strain (3566 in the liver, 561 in the aorta and 3065 in the spleen). Finally, B. fragilis colonization was
also able to restore the EPC decrease observed in mice infected with B. henselae (0.65 vs 0.06 media). Thus, our data
establish that B. fragilis colonization is able to prevent B. henselae damages through PSA.
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Introduction
Intracellular pathogens, including many different bacteria, live
and replicate either within endosomal compartments or in the
cytosol of diverse host cells such as macrophages, dendritic cells,
neutrophils, fibroblasts, epithelial or endothelial cells or erythro-
cytes [1,2].
Bartonella henselae belongs to a group of gram-negative facultative
intracellular bacteria [3]. It is the causative agent of cat scratch
disease, a human infection usually characterized by persistent
regional lymphadenopathy [4,5]. The bacterial pathogenicity and
clinical manifestations depend on the immune status of the
infected host [2,6–8]. Noteworthy, B. henselae is able to adhere and
invade EPCs [9] HSCs (hematopoietic stem cells) [10] other than
human erythrocytes [11,12]. These circulating progenitors had
been previously shown to be resistant to the infection of other
intracellular pathogens [13]. Moreover, these cells have been
suggested to transport B. henselae to peripheral tissues, particularly
to the endothelium of microcirculation where vasoproliferative
disorders occur [2,9].
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On the other hand, Bacteroides fragilis is a gram-negative
anaerobe bacterium and an integral component of the gut
microflora of most mammals [14–18]. This intestinal commensal
is capable of mediating powerful effects on the host immune
system, which are mostly mediated by the capsular polysaccharide
A (PSA), an immunomodulatory molecule that mediates T cell-
dependent immune responses [17–19]. Indeed, it was shown to
protect animals from experimental colitis induced by Helicobacter
hepaticus [20] and this beneficial activity was demonstrated to
require the PSA [20]. This microbial molecule can exert its effects
through the immune system within both the intestinal and the
systemic compartments [21–24].
Thus, in order to gain further insights in our understanding of
how commensal organisms, such as B. fragilis, shape host immunity
in other models, we investigated whether B. fragilis colonization
could protect animal from B. henselae infection and exert beneficial
effects on EPCs and vascular system.
Results
B. fragilis Internalizes Progenitor Cells in vitro and
Competes with B. henselae during Coinfection
To evaluate the possible capacity of either B. fragilis or the
mutant strain defective in the ability to produce PSA (B. fragilis
DPSA) to adhere and invade progenitor cells, we infected in vitro
cultured EPCs with both these bacterial strains at a multiplicity of
infection (MOI) of 100. As control of infection we used B. henselae
at 100 MOI, which has been demonstrated to elicit low cytostatic
effects [9,25]. The presence of bacteria was revealed after 24 h
from infection by confocal microscopy, as shown in Figure 1A.
Immmunofluorescence staining with specific antibodies showed
that both B. fragilis and its mutant DPSA could internalize EPCs as
previously documented for another intracellular pathogen, B.
henselae [9]. Longer times of infection (48 h and 72 h) as well as
higher MOIs showed similar results (see Figure S1–S2). Thus, we
have used a MOI of 100 and 24 h of infection for further
experiments.
We also carried out coinfection experiments with B. fragilis, or B.
fragilis DPSA, and B. henselae on in vitro cultured EPCs (Figure 1B).
A MOI of 100 was used for all bacteria strains. Interestingly, in the
coinfection with B. fragilis a prevalence of Bacteroides was
observed whereas in the coinfection with B. fragilis DPSA the
presence of Bartonella was more evident (Figure 1B). These
findings suggest B. fragilis, but not B. fragilis DPSA, prevents - or at
some extent impairs – the internalization of B. henselae. Cells were
observed after 24 h, 48 h and 72 h (Figure S2).
Overall, these findings clearly demonstrate that both B. fragilis
and B. fragilis DPSA are able to internalize EPCs independently of
PSA. However, only B. fragilis but not B. fragilis DPSA is able to
partially prevent Bartonella internalization.
Analysis of Inflammatory Chemokines and Cytokines
To analyze gene expression changes occurring in cultured EPCs
infected by B. fragilis and B. henselae, and to assess the effect of
DPSA on the transcription of inflammation-related genes, we used
RT2 Profiler PCR Arrays to simultaneously profile 84 inflamma-
tory genes encoding chemokines, cytokines and their receptors, as
recently performed by Sumegi J. et al. [26]. The degree of
differential expression for all the inflammatory genes within all
analyzed samples is schematized in Figure 2A.
Surprisingly, even though in B. henselae-infected EPCs about 30
(out of 84) inflammatory genes were differentially expressed (DE)
compared to uninfected cells, the highest percent of DE genes was
detected in B. fragilis DPSA-infected cells (Figure S3). Particularly,
in these cells 78 inflammatory chemokine and cytokine encoding
genes (about 93% of all analyzed genes) were DE (Figure S3). Of
note, 75 out of 78 DE genes were significantly up-regulated. On
the opposite, infection with the wild-type strain of B. fragilis (i.e.
with intact PSA) led to a decreased number of up-regulated
inflammatory genes (43 vs 75) and a marked reduction in the
expression levels of some crucial genes (Figure 2B).
In addition, we also evaluated the expression of inflammatory
genes during coinfection with B. henselae-B. fragilis and B. henselae-B.
fragilis DPSA compared to the infection with B. henselae alone. We
observed an increased number of DE genes during both
coinfections even though the extent of differential expression of
inflammatory genes was more pronounced in B. henselae-B. fragilis
DPSA cells. In particular, a direct comparison between the
expression levels in the coinfected samples revealed that B. fragilis
exerts a significant down-regulation of pro-inflammatory chemo-
kines (shown in Figure 2C) simultaneously providing a positive
modulation of anti-inflammatory genes such as IL-10 and
Interferon-alpha 2 (IFNA2) (Figure 2D).
We also analyzed an array of secreted cytokines involved in the
inflammation response by enzyme-linked immunosorbent assay
(ELISA) (Figure 2E–2F and Figure S4) on the supernatants of the
same infected cells. For most of analyzed cytokines we observed a
similar trend of differential expression as observed in the analysis
of gene expression levels, even though the extent of DE was
different. In particular, similarly to the results of RT2 Profiler PCR
Arrays analysis, in coinfected samples the wild-type strain of B.
fragilis exerts a significant down-modulation of pro-inflammatory
interleukins (Figure 2E) and, on the opposite, a positive increase of
IL-10, shown to repress in vivo the expression of TNFa and
Granulocyte macrophage colony-stimulating factor (GM-CSF)
(Figure 2F).
Overall, these data indicate a marked activation of the
inflammatory response in B. fragilis DPSA-infected cells, reflecting
both the high ability of such intracellular bacteria to invade EPCs
and possibly the more rapid cell division compared to B. henselae.
Moreover, such data confirm the role of PSA in modulating the
inflammatory response, by both repressing and inducing several
chemokine/cytokine-encoding genes, during in vitro infection of
cultured EPCs.
Murine Infection and Detection of Bacteria in Tissues
from Infected Mice
We have developed a mouse model of coinfection to investigate
whether B. fragilis colonization could protect animal from B.
henselae infection. In order to determine whether PSA is essential
for protection against pathogenic effects of B. henselae, mice were
inoculated with either B. fragilis or its mutant B. fragilis DPSA [20].
Three groups of five mice each (n = 5) were infected with 109 CFU
of either B. henselae or B. fragilis or B. fragilis DPSA respectively,
whereas two groups of animals were coinfected with B. henselae and
alternatively B. fragilis or B. fragilis DPSA (see Figure 3A). No
animals died after infection and the health was evaluated once a
day for the full duration of the experiment. After 36 days, animals
were euthanized in order to assess both the bacterial infection and
B. fragilis protection by histopathology and transmission electron
microscopy (TEM) of infected tissues (see paragraphs below).
The presence of the above-mentioned bacteria was documented
by TEM and immunofluorescence analysis, which was also used to
evaluate the colocalization (fluorescein-rhodamine) of both bacte-
ria in coinfected mice. Bacterial internalization was observed in
the endothelial and subendothelial layers around centrilobular
veins and veins of the portal triads. There is no evidence of the
B. fragilis and B. henselae-Induced Damage
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presence of bacteria within the hepatocytes or between the hepatic
laminae (Figure 3B–3C).
Paraffin-embedded liver samples obtained from infected
animals were also examined for the detection of DNA of both
bacterial species by PCR. Nested-PCR for the gltA gene (encoding
for citrate synthase) (353 bp) and frdA gene (encoding for fumarate
reductase) (354 bp) revealed the presence of B. henselae and B.
fragilis DNA respectively for at least 36 days in the tissues of all
mice examined (Figure 3D). No bacterial DNA was isolated from
control mice (data not shown).
B. fragilis Protects from the Pathogenic Effects of
B. henselae Infection in Mice
Morphological analysis by hematoxylin-eosin. The mor-
phological study performed by hematoxylin-eosin staining showed
the presence of several alterations in both aorta and liver of mice
infected with B. henselae compared to the control uninfected tissues.
In the liver, we observed hydropic degeneration, nuclear pycnosis,
hepatocytes with granular cytoplasm, activation of Kupffer cells
and a granulomatous inflammatory reaction, as described in the
literature (Figure 4) [27,28]. These alterations were localized
predominantly in the perivascular region, in the form of histioid
aggregates with a mild lymphocytic infiltration (Figure 4A).
Interestingly, the granulomatous infiltrates were less invasive in
the group coinfected with B. henselae and B. fragilis DPSA and
almost absent in the group of mice coinfected with B. henselae and
B. fragilis. This was confirmed by the cytopathic effect and the
inflammatory reaction (Figure 4A). Uninfected control, B. fragilis
and B. fragilis DPSA groups were negative for all the described
aspects. In the aorta, we documented minimal lesions in B. henselae
infected mice. Particularly, focal endothelial swelling, with aspects
of hydropic degeneration and hyalinization of basal membranes
were observed (Figure 4B). These changes tend to disappear in the
group of mice infected with B. henselae and B. fragilis DPSA and -
more evident - in the aortas of B. henselae and B. fragilis infected
mice (Figure 4B). In the spleen of B. henselae infected mice we
observed an expansion of the white and red pulp, with a
consequent activation of the reticulo-endothelial system (see
Figure S5). In mice coinfected with B. henselae and B. fragilis DPSA
a reduced inflammatory reaction was observed, with a decreased
reactivity of the reticulo-endothelial system. A dramatic reduction
in the inflammatory reaction was even more evident in B. henselae
and B. fragilis infected mice.
Immunohistochemistry analysis. To confirm the morpho-
logical observations we performed immunohistochemistry assays
on the liver, aorta and spleen with an anti-Bartonella specific
antibody. We determined the relative count of positive cells per
field (HPF) in all analyzed sections (20 fields per each section).
Figure 5 schematically shows the results of such HPF counting for
mice infected with B. henselae, B. henselae/B. fragilis and B. henselae/B.
fragilis DPSA.
In the liver parenchyma of B. henselae infected mice, positive
immunoreactivity to the specific antibody (i.e. infected cells) was
equal to 5068 positive cells 6HPF (Figure 5A). This positivity
decreased in the group of mice infected with B. henselae and B.
fragilis DPSA (35666HPF) (Figure 5A), and further reduced of
about 40% in the mice coinfected with B. henselae and B. fragilis
Figure 1. B. fragilis and B. henselae internalize EPCs. A. Confocal images of human early EPCs infected with B. henselae, B. fragilis and B. fragilis
DPSA at 100 MOI. Cells were stained with anti-Bacteroides (red) or with anti-Bartonella (green) specific antibodies after 24 h from infection. B. EPCs
coinfected with B. henselae, and B. fragilis or B. fragilis DPSA as indicated. A MOI of 100 was used for all bacteria strains. Cells were stained with anti-
Bacteroides (red) and with anti-Bartonella (green) specific antibodies after 24 h from infection.
doi:10.1371/journal.pone.0049653.g001
B. fragilis and B. henselae-Induced Damage
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(2064 6 HPF) (Figure 5A). Few granulomatous lesions were
observed, mainly concentrated in the parenchyma near the
limiting pericentral laminae and, in the area adjacent to the
vessels. Focal positivity in perisinusoidal areas was present.
Infected cells were also detected in the granulomatous formations.
In the aorta, the percentage of B. henselae infected endothelial
cells was minimal, with a count of positive cells of 10626HPF
Figure 2. Expression levels of inflammatory genes in infected EPCs. A. Expression levels of 84 inflammatory genes in EPCs infected with B.
henselae, B. fragilis, B. fragilis DPSA, B. henselae and B. fragilis, B. henselae and B. fragilis DPSA. Differential expression data are evaluated vs uninfected
EPCs. B. Bar graph showing the expression of some relevant differentially expressed genes encoding chemokines, cytokines and their receptors in B.
fragilis- vs B. fragilis DPSA-infected EPCs. Data are shown as relative expression levels (B. fragilis DPSA-infected cells = 1). C. and D. Expression levels of
representative pro-inflammatory (C) and anti-inflammatory (D) genes highly differentially expressed during coinfection of EPCs, in presence and in
absence of PSA. E. and F. Absolute quantification of relevant secreted inflammatory proteins detected by ELISA in the EPCs infected with B. henselae,
and coinfected with B. fragilis and B. fragilis DPSA.
doi:10.1371/journal.pone.0049653.g002
Figure 3. Murine infection with B. henselae and B. fragilis and detection of bacteria in infected tissues. A. Scheme of murine infection:
three groups of C57BL/6J mice (n = 5) were infected with B. henselae, B. fragilis, B. fragilis DPSA respectively and two groups of animals (n = 5) were
coinfected with B. henselae and B. fragilis or B. fragilis DPSA. B. TEM micrographs of the liver of C57BL/6J mice infected with B. fragilis and B. fragilis
DPSA respectively, B. henselae and coinfected. C. Immunofluorescence analysis of the livers of animals infected with B. henselae, B. fragilis and
coinfected. Livers were sectioned and treated with an anti-B. henselae and a Bacteroides LPS primary antibody followed by TRITC- or FITC-conjugated
secondary antibodies respectively. Liver sections from uninfected mice were used as controls (data not shown). Selected merge images of coinfected
mice were acquired by confocal microscopy (Magnification: all, X 270). D. Detection of B. henselae gltA gene and B. fragilis frdA gene by nested-PCR
from the liver samples of experimentally infected C57BL/6J with B. fragilis and B. fragilis DPSA (lane 1–2), B. henselae (lane 3–4), coinfected (lane 5–8),
respectively. Genomic DNA extracted from B. henselae and B. fragilis was used as positive control (lane 9).
doi:10.1371/journal.pone.0049653.g003
B. fragilis and B. henselae-Induced Damage
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(Figure 5B). The endothelium appeared swollen with a slight
fibrous sub-endothelial layer. B. henselae positivity was very
laborious to determine in the aortas of B. henselae and B. fragilis
DPSA coinfected mice, with only 561 6 HPF positive cells
(Figure 5B). The same number of infected cells was also detected in
the group of mice infected with B. henselae and B. fragilis (Figure 5B).
Figure 4. Morphological analysis of murine coinfected tissue by hematoxylin-eosin staining. A. Representative microscope images of
hematoxylin-eosin staining of liver tissues from each group of mice uninfected, infected with B. henselae, B. fragilis and B. fragilis DPSA or coinfected,
as detailed. Granulomatous inflammatory infiltrates are predominantly evident in the group of mice infected with B. henselae compared to the group
infected with B. henselae and B. fragilis DPSA and particularly in the mice coinfected with B. henselae and B. fragilis. Uninfected controls are negative,
as well as B. fragilis and B. fragilis DPSA groups. B. Representative sections stained with hematoxylin-eosin of aortas from all mice groups as
described. In the group of mice infected with B. henselae, minimal lesions are observed in the aorta compared to liver tissues.
doi:10.1371/journal.pone.0049653.g004
B. fragilis and B. henselae-Induced Damage
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The spleen of mice infected with B. henselae had a cellular
positivity to anti-Bartonella antibody of 4066 cells6HPF, mainly
in the red pulp. Focal positivity in the follicular centers was also
evident (Figure S5). The trend of positivity reduction in both
groups of coinfected mice was similar to that observed for liver and
aorta tissues (Figure S5).
The decreased damage and the presence of inflammatory
response in coinfected mice, particularly with B. henselae and B.
fragilis, suggested us a possible pathogenic mechanism related to
bacteria competition within infected cells. This assertion is
corroborated by the presence of both bacteria in the cells and
by a smaller cytopathic effect that attains a less inflammatory
component. An intermediate state of cell damage between the
groups infected with only B. henselae strain and those coinfected is
represented by the group infected with the mutant B. fragilis DPSA.
In this case a reduction of the damage is achieved compared to the
B. henselale infected group, although to a lesser extent compared to
the group of coinfected mice.
Ultrastructural analysis. The ultrastructural analysis
(TEM) performed on the liver of B. fragilis-infected mice
(Figure 6I) revealed a regular architecture of the hepatic tissue
with no evidence of any inflammatory and immune response, as in
the uninfected mice (Figure 6A). In contrast, the observation by
TEM of livers from B. henselae-infected mice revealed the presence
of massive granulomas, due to a B. henselae-induced chronic
inflammatory state (Figure 6B). Such granulomas are character-
ized by the presence of neutrophils and few bacteria (Figure 6B
and S6C), indicating a still ongoing immune response.
Surprisingly, there was any pronounced inflammatory response
in the liver samples of mice coinfected with B. henselae and the wild
type strain of B. fragilis (Figure 6E). Within these samples, the
ultrastructural analysis revealed only few macrophages in the
portal triads and around the centrilobular veins (Figure S6DII).
Moreover, since the role of B. fragilis PSA on inflammatory
and immune-regulatory responses, ultrastructural analysis was
also performed on the liver samples from mice infected with B.
fragilis DPSA (see Methods) (Figure 6J). Such analysis revealed the
presence of regular hepatic tissue architecture with no evidence
of inflammatory/immune response, with the presence of active
Kupffer cells in the hepatic sinusoids (Figure S6BI). On the
opposite, in the livers of mice coinfected with B. henselae and B.
fragilis DPSA, TEM showed again the presence of granulomas
(Figure 6F), even though smaller than those observed in B.
henselae-infected mice, confirming the role of PSA in the
immunomodulation.
In all analyzed mice we did not observe the massive presence of
bacteria, neither of invasomes, but few individual bacteria were
visible in the space of Disse or in the granulomas (Figure S6A–EI).
The same ultrastructure investigations were then conducted on
aorta’s sections isolated from control (Figure 6C) and infected mice
(Figure 6 panels D, G, H, K and L). We did not observe the
presence of granulomatous formations in any of the samples
analyzed. The only exception is the presence of white cells, not
organized to form a granuloma, observed in the adventitia of the
aorta of B. henselae-infected mice (Figure 6D). Aorta, in all analyzed
samples, has not significant morphological alterations, except for a
Figure 5. Morphological analysis of murine coinfected tissue
by immunohistochemistry. A. Representative images of immuno-
histochemistry analysis of murine liver samples with an antibody
against B. henselae are shown (206X magnification). Bar graphs show
the mean of the positive cell number per field (HPF) as indicated. 20
fields per each section were analyzed and bars represent standard
deviations. B. Immunohistochemistry analysis of murine aorta samples.
doi:10.1371/journal.pone.0049653.g005
B. fragilis and B. henselae-Induced Damage
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Figure 6. Ultrastructural analysis of murine infected tissue. Electron microscopy of liver and aorta: A. Portal triad of normal liver. B.
Granuloma around a centrilobular vein of the liver infected with B. henselae with a characteristic neutrophil. C. Normal aortic intima and media. D.
B. fragilis and B. henselae-Induced Damage
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marked swelling of the endothelial layer visible in B. henselae-
infected samples (Figure S6HII), and in samples coinfected with B.
henselae and B. fragilis, respectively wild type and DPSA strains
(Figure 6G–6H). These bulges may be regarded as a reaction of
the organ to bacteria passage, in particular of B. henselae, indeed,
they have not been found in the aortas of mice infected with either
B. fragilis and B. fragilis DPSA (Figure 6K–6L). Even in the aorta,
we did not observe a massive number of bacteria and of
invasomes, but they were found only sporadically (Figure S6F–JI).
EPC number in infected mice. At 36 days after infection,
before mice sacrifice, blood was collected in order to establish
whether the EPC number was influenced by infection in all the
studied groups. As shown in Figure 7, the mean number of EPCs,
measured as Sca-I/Flk-I positive cells, dramatically decreased of
about 90% in mice infected with B. henselae (0.06) compared to the
uninfected group, whose EPC number was considered as 100%
(1.0). Means were calculated by standard error method. This
number was partially restored in mice coinfected with B. fragilis or
B. fragilis DPSA and B. henselae (0.65 and 0.42 means respectively).
Thoroughly, these results indicate that B. fragilis, but not B.
fragilis DPSA, is able to prevent the decrease of EPC induced by B.
henselae infection.
Discussion
The results of this study establish that: 1) B. fragilis is able to
adhere and invade EPCs; 2) B. fragilis competes with B. henselae
during in vitro coinfection assays; 3) the immunomodulatory
properties of B. fragilis depend on PSA; 4) damages induced by
B. henselae in liver and aorta of infected mice can be prevented by
colonization with B. fragilis but not with its mutant B. fragilis DPSA;
5) EPC impairment prompted by B. henselae can be counteracted
by B. fragilis colonization.
Our in vitro studies indicate that B. fragilis is able to adhere and
invade EPCs and it competes with B. henselae during coinfection.
Furthermore, we observed a marked activation of inflammatory
response in B. fragilis-infected cells compared to B. henselae-infected,
as determined by Real time PCR and ELISA of pro-inflammatory
chemokines and cytokines. In the mouse model of coinfection,
morphological and ultrastructural analyses showed that the
damage induced by B. henselae in liver and aorta can be prevented
in the coinfection with B. fragilis but not with its mutant B. fragilis
DPSA. Specifically, the number of B. henselae-positive cells per field
counted by immunohistochemistry analysis decreased of at least
50% in the liver, spleen and aorta sections of mice coinfected with
both bacteria compared to mice infected only with B. henselae. This
reduction was less evident in the tissue from mice coinfected with
B. fragilis DPSA suggesting a possible role of the PSA also in this
model. Finally, B. fragilis colonization was also able to restore the
EPC number decrease observed in mice infected with B. henselae.
The findings of this complex study were achieved by performing
a great bulk of experiments in vitro as well as in vivo. We have
previously demonstrated that B. henselae internalizes EPCs [9,29],
also documenting the gene expression changes occurring during
infection [9,30]. A further study indicated that EPCs can be also a
potential reservoirs of Kaposi’s sarcoma-associated herpesvirus
[31], thus extending our findings to other microorganisms.
Noteworthy, this is the first study demonstrating that also B.
fragilis can adhere to and invade EPCs as shown by confocal
observations. Moreover, its internalization is not fully dependent
on PSA since also the mutant DPSA strain exhibits such ability.
This important finding has been achieved both in vitro on EPCs by
confocal microscopy (Figure 1) and in vivo on infected mice tissues
analyzed by ultrastructural analysis (Figure 6 and S6). To our
knowledge, TEM examination has been used only in a few in vitro
studies to explore cell internalization of B. fragilis but never for B.
fragilis DPSA [32,33]. A previous study showing the ability of B.
White cells in the tunica adventitia of aorta infected with B. henselae. E. Centrilobular vein of liver coinfected with B. henselae and B. fragilis. F.
Granuloma in liver coinfected with B. henselae and B. fragilis DPSA. G. Endothelium bulging of aorta coinfected with B. henselae and B. fragilis. H.
Endothelium bulging of aorta coinfected with B. henselae and B. fragilis DPSA. I. Centrilobular vein of liver infected with B. fragilis. J. Centrilobular vein
of liver infected with B. fragilis DPSA. K. Endothelium of aorta infected with B. fragilis. L. Endothelium of aorta infected with B. fragilis DPSA.
doi:10.1371/journal.pone.0049653.g006
Figure 7. EPC number of infected mice. EPC relative number of infected mice versus control mice was measured by FACS analysis. Sca-I/Flk-I
double positive cells were considered as murine EPCs. Bars indicate standard errors.
doi:10.1371/journal.pone.0049653.g007
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fragilis PSA to stimulate an anti-inflammatory background in the
intestine suggested that PSA may be critical for the establishment
of a commensal intestinal flora [34]. Indeed, colonization
experiments indicated that B. fragilis DPSA could not colonize
the colonic epithelium as efficiently as the wild type strain [34].
Such different capability in tissue colonization has suggested that
PSA may function as an adherence factor for B. fragilis, or reflect
the immunomodulatory properties of PSA [18]. The protective
role of B. fragilis, recently shown to be sufficient to correct some
immune system deficiencies in the absence of bacterial coloniza-
tion, and also to prevent intestinal inflammation in animal models
of colitis [19,20].
Our results corroborate the latter hypothesis. Indeed, on one
side, both strains are able to adhere and invade cells, indepen-
dently of the presence of PSA; on the other side, we confirmed the
PSA immunomodulation ability through the analysis of inflam-
matory chemokine/cytokine during in vitro infection of EPCs.
In our previous study [9], we also showed the detrimental effects
of B. henselae on EPC number as well as the deregulation of
inflammatory gene networks after in vitro infection [30]. Here, we
document in vivo the Bartonella-induced damage in the tissues of
infected mice, also showing for the first time a dramatic decrease
in EPC number compared to uninfected control mice. Interest-
ingly, B. fragilis colonization was also able to restore the EPC
number decrease occurring in mice infected with B. henselae (0.65 vs
0.06 means).
The absence of a marked inflammatory response evidenced by
TEM in mice coinfected with B. fragilis and the presence of
granulomas in the liver as well as of cells of the immune system in
the adventitia of mice infected with only B. henselae are all signs of
the protective effect of the PSA molecule of Bacteroides. This effect
was also evidenced by a weaker inflammatory response in mice
coinfected with B. fragilis DPSA. This finding suggests that even
other molecules could be involved in the process of immunoreg-
ulation and exert a protective effect.
Moreover, a previous paper has shown that toxins of B. fragilis
modify the actin cytoskeleton inducing disruption of intercellular
junctions [35]. However, we have seen cellular junctions perfectly
arranged between the liver cells (data not shown); this result
indirectly demonstrates the inability of these bacteria to invade the
liver cells, as observed in our TEM data where bacteria are seen
only in endothelial cells or in the space of Disse.
In coinfected mice we also documented a decreased presence of
granulomas in liver and minimal changes in aorta, thus
demonstrating both the tissue damage reduction and a lower
presence of B. henselae within the cells, with a consequent decrease
in its cytopathic effect. In few granulomas we found a lower
extension and an intracellular colocalization at the immunofluo-
rescence with B. fragilis. According to colocalization experiments,
we can assess that the expression of granulomas is due to a
protective effect of B. fragilis that competes with B. henselae for
adhesion sites, leading to a lower cytopathic effect, reduced
necrosis and impaired release of pro-inflammatory molecules,
resulting in a global protective effect. We can therefore conclude
that the reduced amount of infected cells in coinfected mice leads
to impaired cellular suffering, occurring in the few cells where both
bacteria colocalize and where B. henselae-induced cytotoxic effect is
exhibited. The lower cytotoxic effect is likely to be a direct
consequence of the reduced expression of several inflammatory
molecules and, in turn, an impaired inflammatory response
(immunohistochemical data). Such process is usually related with
the pathogenicity of a bacterial agent. The increase of the cell
damage induced by B. henselae is shown in our model by an
inflammatory infiltrate that is more conspicuous in the liver.
Taking together our data strongly indicate that B. fragilis
protects from B. henselae induced damages, including vascular ones.
This relevant finding may provide a basis for the development of
novel therapies against such infections.
Materials and Methods
Bacterial Strains and Growth Conditions
The B. henselae strain ATCC49882 (LGC Promochem) was
stored at 280uC in tryptone soya broth USP (TSB) (Oxoid) until
use, and grown on Columbia agar supplemented with 5%
defibrinated sheep blood (Oxoid) in a humidified atmosphere at
37uC and 5% CO2 for seven days. B. fragilis NCTC9343 and its
mutant B. fragilis DPSA were kindly provided by Professor Dennis
L. Kasper. The strains were stored at 280uC in brain heart
infusion broth (Oxoid) until use, and grown anaerobically onto
Schaedler agar with 5% sheep blood at 37uC for 48 h.
EPC Isolation and Cultivation
Human EPCs were isolated from total peripheral blood
mononuclear cells (PBMCs) as previously described in detail
[9,36,37]. Written informed consent was obtained from donors
according to the Declaration of Helsinki.
In vitro EPC Infections
For in vitro infection experiments, B. henselae, B. fragilis and B.
fragilis DPSA stock solutions were thawed, washed, suspended in
antibiotic-free cell culture medium. Cultured EPCs were infected
with B. henselae at multiplicity of infection (MOI) of 100 [9]. B.
fragilis or B. fragilis DPSA were used at MOI of 100, 200, 400 to
establish optimal concentrations in vitro. Bacteria were sedimented
onto 3 days cultured EPCs by centrifugation at 18006g for 59 at
room temperature (RT). Following 24–48–72 h of incubation the
EPCs were infected with B. fragilis or B. fragilis DPSA and/or B.
henselae. Coinfection with B. henselae was performed either at the
same time or after 3 h of B. fragilis or B. fragilis DPSA infection.
The cultures were stopped at the established time and EPCs were
washed three times with phosphate buffer solution (PBS) to
remove non-adherent bacteria. For selective removal of extracel-
lular bacteria, 100 mg/ml gentamicin (Schering-Plough) was
added. To determine CFU [9], the cells were washed 2 h with
PBS after addition of gentamicin, lysed by the addition of ice-cold
distilled water, and incubated for 59 on ice. The MOI used for
each experiment was confirmed by plating serial dilutions.
Confocal Immunofluorescence Microscopy
Cultured cells were fixed with 3% paraformaldehyde for 209 at
RT and permeabilized with 0.1%Triton-X100. Cells were then
incubated 609 at RT with specific antibodies. Anti-B. henselae
primary antibody (Novus Biologicals), diluted 1/100, was then
revealed with secondary antibodies conjugated to Alexa Fluor 488
(1:500; Invitrogen, Carlsbad, CA) for 309 at RT. Anti-B. fragilis
Lipopolysaccharides (LPS) primary antibody (Santa Cruz Bio-
technology, INC.) was diluted 1/250 and revealed with secondary
antibody conjugated with tetramethylrhodamine isothiocyanate,
diluted 1/20 (TRITC, Dako). Microscopy was performed using
Zeiss LSM 510 confocal microscope equipped with a plan-
apochromat x40 (NA 1.4) oil immersion objective and cropped to
higher magnification. Fluorescence emissions were acquired in
multi-track mode using LP 505 filter. To minimize noise, each
image was averaged three times.
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Measurement of Cytokines in Cell Culture Supernatants
Cell-free supernatants were collected from infected EPCs and
assayed for levels of cytokines and chemokines by commercial
enzyme-linked immunosorbent assay (ELISA) kits according to the
manufacturer’s instructions (SABiosciences A Qiagen Company).
The concentrations of cytokines (pg/ml) IL1A, IL 1B, L2, IL4,
IL6, IL8, IL10, IL12, IL17A, IFNc, TNFa and GM-CSF were
measured using an ELISA reader (Tecan). Results are presented as
mean error of the values 6 standard mean. The Student’s t test
was used for the comparison of means, and regression analysis was
used to evaluate any correlation between different cytokine levels.
A P value of ,0.05 was considered significant.
RNA Isolation and Quantitative Real-Time PCR Assays
Total RNA was isolated from in vitro cultured EPCs infected
with B. henselae, B. fragilis, B. fragilis DPSA and uninfected, using
standard TRIZOL (Invitrogen) protocol as previously described
[37,38]. Integrity and concentration were evaluated by gel
electrophoresis and Nanodrop. The RNA quality of each sample
was good, with 260/280 ratio in the range between 1.8 and 2.0.
All purified RNAs were then converted into cDNA using the RT2
First Strand Kit (SABiosciences, Frederick, USA). Resulting
cDNAs were used for the quantitative Real-Time PCR assays
performed on a specific RT2 ProfilerTM PCR Arrays (SABios-
ciences) [26].
In particular, samples were analyzed on the 96-well plate
Human Inflammatory Cytokines & Receptors RT2 Profiler PCR
Arrays (PAHS-011). Such arrays provide a mix between the large-
scale ability of microarrays to analyze gene expression and the
quantitative sensitivity of Real-Time PCR assay, with highly
reproducible results.
A total of 89 genes (including 5 house-keeping genes) was
analyzed on this PCR-array for each sample. Briefly, cDNAs were
independently added to the RT2 SYBR Green qPCR Master Mix
(SABiosciences, Frederick, USA) and then spotted on 6 Human
Inflammatory Cytokines & Receptors PCR-arrays. All the
experimental procedure was performed according to the manu-
facturer’s instructions for the 7900HT Real Time PCR system
(Applied Biosystems). Melting curves were generated after the
amplification of 40 cycles.
Relative gene expression was measured by using the 22DDCt
method. Values of threshold cycle (Ct) were converted to 22Ct in
order to be proportional to the amount of transcripts in the
samples. Ct values $35 cycles were considered undetectable. In
order to compare the samples among them, 22DCt were calculated
by normalizing expression data by the mean of housekeeping
genes (as specified for PCR-Arrays). For comparing gene
expression data derived from the different experimental condi-
tions, we calculated 22DDCt values, obtained by normalizing
experimental data by reference data (uninfected EPCs) [26]. Data
derived from such analysis were also checked by using an Excel
sheet downloaded from the manufacturer’s website (http://www.
sabiosciences.com/pcrarraydataanalysis.php). For each PCR re-
action, the Excel sheet allows data normalization correcting all Ct
values by the average Ct values of constantly expressed house-
keeping genes present on the array. In our experiments we
observed that among the standard housekeeping genes, Hypoxan-
thine-guanine phosphoribosyltransferase (HPRT) was highly var-
iable among samples, thus it was not considered for further
normalization of data. Differentially expressed genes were defined
as those with at least 2-fold change variation.
Ethics Statement
The mice were fed with laboratory food pellets and tap water ad
libitum, and were bred and housed under specific pathogen free
conditions at CEINGE-Advanced Biotechnologies, Naples, Italy.
All animal experiments were carried out according to institutional
guidelines. All efforts were made to minimize animal suffering and
to reduce the number of mice used, in accordance with the
European Communities Council Directive of November 24, 1986
(86/609/EEC). The protocol of the study has been reviewed and
approved by Ethical Animal Care and Use Committee ‘‘Federico
II’’ University of Naples, Prot. 2012/0085083.
Murine Strains and Infection
Specific pathogens free (SPF) C57BL/6J, female mice 8 weeks
of age, were purchased from Charles River Laboratory. B. fragilis
or B. fragilis DPSA was given to animals in concentration 109 CFU
in 0.1 ml of PBS per mouse by oral administration. Mouse enteric
colonization was initiated 7 days prior to B. henselae infection, and
the bacterial suspension was given 4 times on alternate days. B.
henselae was prepared as described above and thawed on ice prior
to infection. Mice were infected with B. henselae via intraperitoneal
route at dose of 109 CFU/mouse suspended in TSB. Control mice
were injected with the same medium in the absence of bacteria.
Following infection, mice were observed daily for signs of illness.
At indicated time after infection (36 days) blood was withdrawn by
cardiac puncture before sacrifice and collected in heparinized
tubes. At the times of euthanasia, liver, spleen and aorta were
excised and fixed for molecular and microscopic analysis.
Detection of B. henselae and B. fragilis DNA by PCR
To determine the presence of bacterial DNA in mouse tissue,
we developed a nested-PCR assay to amplify a fragment of the B.
henselae gltA gene (outer: 674 bp; inner: 353 bp) [28] and B. fragilis
frdA gene (outer: 599 bp; inner: 354 bp). Slices of infected liver
tissue (20 mm thick), from paraffin-embedded organs, were
provided by the Comparative Pathology Facility of CEINGE-
Advanced Biotechnologies. DNA was isolated by using the
QIAamp tissue extraction kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s protocol.
PCR was performed with AmpliTaq Gold polymerase (Applied
Biosystems) in a volume of 50 ml in two sequential tubes. Following
initial denaturation for 49 at 95uC, amplification with outer
primers was performed with 30 cycles of 19 at 94uC, 19 at 70uC,
and 29 at 72uC. Amplification with inner primers consisted of 30
cycles of 19 at 94uC, 109 at 30uC, and 19 at 72uC. The final
extension step was extended to 109 in both rounds of PCR. Several
negative controls were included to exclude cross-contamination
[28]. The expected amplicons were visualized by electrophoresis in
an agarose gel and by staining with ethidium bromide. The
expected amplicons were detected by using two primer pairs:
OuterBh R/L (674 bp), InnerBh R/L (353 bp); OuterBf R/L
(599 bp), InnerBf R/L (353 bp) (Supporting information Table
S1); due to the small number of bacterial cells in the analyzed
sample, the Outer amplicons are not detectable by electrophoresis.
The assay confirmed the presence of B. henselae, B. fragilis and B.
fragilis DPSA in infected and coinfected tissue samples. PCR was
repeated twice from two different DNA liver samples.
Immunohistochemistry
All samples (liver, spleen and aorta) for immunohistochemistry
were fixed in formaldehyde (4%), embedded in paraffin and sliced
into 5 mm thick sections were cut; one slide was stained with
haematoxylin-eosin to verify the presence of a sufficient amount of
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bacterial cells and the remaining were used for IHC analyses. After
de-paraffinization, slides containing two serial sections were
processed for heat-induced epitope retrieval. When cooled, slides
were washed in PBS and then incubated for 609 at 37uC with the
primary antibody. Arterial segments, livers and spleens were
stained with a mouse monoclonal antibody anti-B. henselae diluted
1/100 (Novus Biologicals). After a further wash in PBS, sections
were incubated with the secondary antibody biotinylated for 159 at
37uC. Epitopes recognized by the primary antibody were detected
by an avidin-biotin-peroxidase method [39]. A count of positive
cells per field (at 2066magnification) was made and 20 fields per
each section were analyzed. The relative means and standard
deviation (6SD) were calculated.
Immunofluorescence
A number of staining procedures were available for localizing
antigen-antibody reaction in tissue by fluorescence. Combination
of either fluorescein- and rhodamine-conjugated antibodies in a
single solution using the direct staining method will simultaneously
detect two antigens in the same section. Liver tissues were
collected, preserved and fixed as for immunofluorescence staining,
were incubated with the two antisera in two different times (two-
step method). Briefly, sections were deparaffinized and then
applied normal serum. Samples were incubated with B. henselae
primary antibody (Novus Biologicals), diluted 1/100, and washed
in TRIS-HCl buffer. Samples were incubated with secondary
antibody conjugated with tetramethylrhodamine isothiocyanate,
diluted 1/20 (TRITC, Dako) and then washed. Sections were
incubated with B. fragilis LPS primary antibody (Santa Cruz
Biotechnology, INC.), diluted 1/250 washed in TRIS-HCL buffer,
and incubated with secondary antibody conjugated with fluores-
cein isothiocyanate diluted 1/20 (FITC, Dako) and then washed.
Antibodies incubation time was 1 h for each step. The observation
was performed with a Confocal Microscope LSM 510 (Zeiss) by
three independent observers.
Transmission Electron Microscopy (TEM)
The aorta and liver tissues were cut into 1 mm3 blocks and fixed
in 1.5% glutaraldehyde in 0,067 M cacodylate buffer at pH 7.4
[40]. The samples were left in fixative for 3 h at 4uC and then
washed in 0,134 M cacodylate buffer, pH 7.4, at 4uC. Then they
were post-fixed in 1% osmium tetroxide in 0,067 M cacodylate
buffer, pH 7.4, at 4uC for 1 h and after washed in 0,134 M
cacodylate buffer, pH 7.4, at 4uC. Fixed tissues were dehydrated
in ascending series of ethyl alcohol and then embedded in epon.
Semi-thin (1,5 mm) sections of TEM embedded liver and aorta
samples were cut with a glass knife for light microscopic
observations. Sections were stained with 1% toluidine blue
solution prepared in 1% sodium tetraborate buffer. Ultra-thin
(50–80 nm) section were cut and stained first with uranyl acetate
3% in 50% ethyl alcohol and then with 2,6% lead citrate. These
sections, loaded on 200 mesh grids, were observed in a JEM-1011
(JEOL) transmission electron microscope at 100 kV.
EPC Number in Infected Mice
A single blood aliquot was collected by cardiac puncture from
the ventricle under anaesthesia, with Tribromoethanol 240 mg/
Kg, using appropriate size needles and collected into heparin-
coated tubes. A volume of 100 ml blood was incubated for 309 in
the dark with Fluorescein isothiocyanate (FITC)-conjugated
monoclonal antibody against mouse (Ly-6A/E) Phosphatidylino-
sitol-anchored protein (Sca-1) (BD Pharmingen) and Phycoery-
thrin (PE)-conjugated antibody against mouse Fetal liver kinase 1
(Flk-1) (BD Pharmingen). Isotype-identical IgG antibodies were
used as controls (BD Pharmingen) [41–43]. After incubation,
erythrocytes were lysed using FACS lysing solution (Becton-
Dickinson), washed with PBS and analysed on a FACScan
(Becton-Dickinson) using CellQuest software. Each analysis
included approximately 10000 events, referred to the total number
of white cells.
Supporting Information
Figure S1 Bacteroides EPC internalization at different
MOIs. Confocal images of human early EPCs infected with B.
fragilis and B. fragilis DPSA at 100, 200 and 400 MOI. Cells were
stained with anti-Bacteroides (red) specific antibody after 48 h
from infection.
(TIF)
Figure S2 Bacteroides and Bartonella EPC coinfection.
EPCs coinfected with B. henselae, and B. fragilis or B. fragilis DPSA as
indicated. A MOI of 100 was used for all bacteria strains. Cells
were stained with anti-Bacteroides (red) and with anti-Bartonella
(green) specific antibodies after 24 h, 48 h and 72 h from
infection.
(TIF)
Figure S3 Differential expression of inflammatory
genes in infected EPCs. Percentage of differentially expressed
inflammatory genes after EPC infection with B. henselae, B. fragilis,
B. fragilis DPSA, B. henselae and B. fragilis, B. henselae and B. fragilis
DPSA respectively, compared to uninfected EPCs.
(TIF)
Figure S4 Levels of secreted inflammatory cytokines in
infected EPCs measured by ELISA. Bar graph showing the
ELISA results from an array of 12 secreted cytokines involved in
the inflammation response.
(TIF)
Figure S5 Morphological analysis of murine infected
spleen by hematoxylin-eosin and immunohistochemis-
try. A. Representative microscope images of hematoxylin-eosin
staining of spleen tissues from each group of mice uninfected,
infected with B. henselae, B. fragilis and B. fragilis DPSA or
coinfected, as detailed. B. Immunohistochemistry analysis of
murine spleen samples with an antibody against B. henselae is
shown (2066 magnification). Bar graphs show the mean of the
positive cell number per field (HPF) as indicated.
(TIF)
Figure S6 Electron microscopy analysis of liver (panels
A–E) and aorta (panels F–L) from infected mice. A. B.
fragilis (arrow). AI. Detail of panel A. B. B. fragilis DPSA (arrow).
BI. Sinusoidal Kupffer cell with evident phagolysosome. C. B.
henselae (arrow) in a granuloma with a characteristic neutrophil. CI.
B. henselae in the endothelial layer. D. Bacterium in the sub-
endothelial layer of liver coinfected with B. henselae and B. fragilis
(arrow). DI. Detail of figure D. DII. Macrophage around
centrilobular vein. E. Bacterium in the sub-endothelial layer of
liver coinfected with B. henselae and B. fragilis (arrow). EI. Detail of
image E. F. B. fragilis in the tunica intima (arrow); FI. B. fragilis in
the tunica media (arrow). G. B. fragilis DPSA in the tunica intima
(arrow). GI. B. fragilis DPSA in the tunica media (arrow). H. B.
henselae in the tunica intima (arrow). HI. B. henselae in the tunica
media (arrow). HII. Swollen endothelium of aorta infected with B.
henselae. I. Bacterium in the tunica intima of aorta coinfected with
B. henselae and B. fragilis (arrow). II. Bacteria in the tunica media of
aorta coinfected with B. henselae and B. fragilis (arrow). J. Bacteria
in the tunica intima of aorta coinfected with B. henselae and B.
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fragilis DPSA (arrow). JI. Bacteria in the tunica media of aorta
coinfected with B. henselae and B. fragilis DPSA (arrow).
(TIF)
Table S1 Oligonucleotides used in this study.
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